Michael Celano - 16 Sep 2022 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Role
Chief Financial Officer
Signature
/s/ Jennifer Johansson, Attorney-in-fact
Issuer symbol
LRMR
Transactions as of
16 Sep 2022
Net transactions value
+$100,000
Form type
4
Filing time
19 Sep 2022, 07:00:34 UTC
Previous filing
16 Aug 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRMR Common Stock Purchase $100,000 +31,746 $3.15 31,746 16 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022.